Cargando…
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164509/ https://www.ncbi.nlm.nih.gov/pubmed/34062183 http://dx.doi.org/10.1016/j.jinf.2021.05.029 |
| _version_ | 1783701132232622080 |
|---|---|
| author | Pezzati, Laura Giacomelli, Andrea Mileto, Davide Conti, Federico Gagliardi, Gloria Rizzo, Alberto Milazzo, Laura Schiuma, Marco Covizzi, Alice Siano, Matteo Bassoli, Cinzia Passerini, Matteo Piscaglia, Marco Torre, Alessandro Oreni, Letizia Rizzardini, Giuliano Galli, Massimo Ridolfo, Anna Lisa Antinori, Spinello |
| author_facet | Pezzati, Laura Giacomelli, Andrea Mileto, Davide Conti, Federico Gagliardi, Gloria Rizzo, Alberto Milazzo, Laura Schiuma, Marco Covizzi, Alice Siano, Matteo Bassoli, Cinzia Passerini, Matteo Piscaglia, Marco Torre, Alessandro Oreni, Letizia Rizzardini, Giuliano Galli, Massimo Ridolfo, Anna Lisa Antinori, Spinello |
| author_sort | Pezzati, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8164509 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81645092021-06-01 Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine. Pezzati, Laura Giacomelli, Andrea Mileto, Davide Conti, Federico Gagliardi, Gloria Rizzo, Alberto Milazzo, Laura Schiuma, Marco Covizzi, Alice Siano, Matteo Bassoli, Cinzia Passerini, Matteo Piscaglia, Marco Torre, Alessandro Oreni, Letizia Rizzardini, Giuliano Galli, Massimo Ridolfo, Anna Lisa Antinori, Spinello J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-09 2021-05-29 /pmc/articles/PMC8164509/ /pubmed/34062183 http://dx.doi.org/10.1016/j.jinf.2021.05.029 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Pezzati, Laura Giacomelli, Andrea Mileto, Davide Conti, Federico Gagliardi, Gloria Rizzo, Alberto Milazzo, Laura Schiuma, Marco Covizzi, Alice Siano, Matteo Bassoli, Cinzia Passerini, Matteo Piscaglia, Marco Torre, Alessandro Oreni, Letizia Rizzardini, Giuliano Galli, Massimo Ridolfo, Anna Lisa Antinori, Spinello Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine. |
| title | Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine. |
| title_full | Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine. |
| title_fullStr | Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine. |
| title_full_unstemmed | Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine. |
| title_short | Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine. |
| title_sort | rapid lateral-flow immunochromatographic tests to assess anti n/s igg seropositivity after bnt162b2 vaccine: a cross-sectional study: rapid lateral-flow immunochromatographic tests after bnt162b2 vaccine. |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164509/ https://www.ncbi.nlm.nih.gov/pubmed/34062183 http://dx.doi.org/10.1016/j.jinf.2021.05.029 |
| work_keys_str_mv | AT pezzatilaura rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT giacomelliandrea rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT miletodavide rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT contifederico rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT gagliardigloria rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT rizzoalberto rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT milazzolaura rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT schiumamarco rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT covizzialice rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT sianomatteo rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT bassolicinzia rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT passerinimatteo rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT piscagliamarco rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT torrealessandro rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT oreniletizia rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT rizzardinigiuliano rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT gallimassimo rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT ridolfoannalisa rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine AT antinorispinello rapidlateralflowimmunochromatographicteststoassessantinsiggseropositivityafterbnt162b2vaccineacrosssectionalstudyrapidlateralflowimmunochromatographictestsafterbnt162b2vaccine |